LIN Form 3: Desiree Bacher Reports Shares, RSUs and Stock Options

Rhea-AI Filing Summary

Report summary: This Form 3 discloses initial beneficial ownership by Desiree Bacher, identified as SVP, Chief HR Officer of Linde plc (LIN). She directly holds 139 ordinary shares and beneficial ownership of multiple equity awards including restricted stock units, deferred stock units and stock options.

Specifically, the filing lists restricted stock units that will convert one-for-one to ordinary shares: 309 units vesting ~03/07/2028, 300 units vesting ~03/07/2027, and 260 units vesting ~03/07/2026. Stock options cover 2,168 shares exercisable beginning 03/07/2026 (strike $468.77), 1,920 shares beginning 03/07/2025 ($465.29), and 1,690 shares beginning 03/07/2024 ($354.14). There are also 40.669 deferred stock units under the Linde Compensation Deferral Plan.

Positive

• Officer ownership disclosed: Desiree Bacher holds direct shares and equity awards, aligning executive interests with shareholders
• Long-term incentives: RSUs, deferred stock units and multi-year option vesting reinforce retention and performance alignment

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Initial Form 3 shows officer ownership and standard long-term incentive awards, indicating alignment with shareholder interests but no material governance event.

The filing documents an executive-level equity stake comprised of a modest number of direct shares and several deferred and performance-linked instruments typical for senior HR leadership. The staggered vesting schedules for restricted stock units and multi-year option vesting reinforce retention incentives. There is no disclosure of extraordinary compensation arrangements or related-party transactions. Overall, this is a routine disclosure that provides transparency on insider holdings.

Compensation Analyst

TL;DR: Holdings include RSUs, DSUs and multi-tranche options with strike prices and vesting timelines consistent with standard executive packages.

The details show three RSU grants with defined payout dates in 2026–2028 and three option grants vesting over three years each, with exercise prices of $354.14, $465.29 and $468.77. The presence of deferred stock units under the Plan indicates tax- or retirement-focused deferral. These elements suggest a pay mix emphasizing equity retention rather than immediate cash, aligning executive incentives with long-term shareholder value creation.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bacher Desiree

(Last) (First) (Middle)

C/O LINDE PLC

FORGE, 43 CHURCH STREET WEST

(Street)

WOKING SURREY X0 GU216HT

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/01/2025

3. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief HR Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	139	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Ordinary Shares	309	(1)	D
Restricted Stock Units	(2)	(2)	Ordinary Shares	300	(2)	D
Restricted Stock Units	(3)	(3)	Ordinary Shares	260	(3)	D
Stock Options (right to buy)	(4)	03/07/2035	Ordinary Shares	2,168	$468.77	D
Stock Options (right to buy)	(5)	03/07/2034	Ordinary Shares	1,920	$465.29	D
Stock Options (right to buy)	(6)	03/07/2033	Ordinary Shares	1,690	$354.14	D
Deferred Stock Units	(7)	(7)	Ordinary Shares	40.669	(8)	D

Explanation of Responses:

1. Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.

2. Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

3. Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

4. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.

5. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

6. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

7. Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.

8. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

Remarks:

	Anthony M. Pepper as attorney-in-fact	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Desiree Bacher disclose on the Form 3 for Linde plc (LIN)?

The Form 3 discloses 139 direct ordinary shares, RSUs (309; 300; 260), stock options (2,168; 1,920; 1,690) with listed exercise prices, and 40.669 deferred stock units.

When do the restricted stock units and options vest according to the filing?

RSUs payout on or about 03/07/2026, 03/07/2027 and 03/07/2028; options vest over three years with initial vesting dates beginning 03/07/2024, 03/07/2025 and 03/07/2026 depending on the grant.

What are the exercise prices for the stock options disclosed by Desiree Bacher?

The filing lists option exercise prices of $354.14, $465.29, and $468.77 for the respective option grants.

Are the deferred stock units convertible to ordinary shares?

Yes. The deferred stock units are converted to Linde plc ordinary shares on a 1-for-1 basis in accordance with the Linde Compensation Deferral Plan.

Does this Form 3 indicate any sale or disposition of shares?

No. The Form 3 is an initial statement of beneficial ownership and only lists holdings and awards; it does not report any sales or dispositions.